Showing results (401-410 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|August 8, 2017
Best practice in the management of behavioural and psychological symptoms of dementiaOlivier Pierre Tible, Florian Riese, Egemen Savaskan, et al.Therapeutic Advances in Neurological Disorders|July 2, 2016
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot studyThomas Müller, Thomas Herrling, Sven Lütge, et al.Therapeutic Advances in Neurological Disorders|July 2, 2016
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapiesKathrin S Utz, De-Hyung Lee, Alexandra Lämmer, et al.Therapeutic Advances in Neurological Disorders|July 2, 2016
Immunoadsorption in patients with neuromyelitis optica spectrum disorderSimon Faissner, Johanna Nikolayczik, Andrew Chan, et al.Therapeutic Advances in Neurological Disorders|July 2, 2016
Web-based interventions in multiple sclerosis: the potential of tele-rehabilitationAlexander Tallner, Klaus Pfeifer, Mathias MäurerTherapeutic Advances in Neurological Disorders|November 25, 2015
The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratioApostolos Safouris, Nikos Triantafyllou, John Parissis, et al.Therapeutic Advances in Neurological Disorders|November 25, 2015
Progressive multifocal leukoencephalopathy: current treatment options and future perspectivesDejan Pavlovic, Andriani C Patera, Fredrik Nyberg, et al.Therapeutic Advances in Neurological Disorders|November 25, 2015
Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndromeAn-Sofie Schoonjans, Lieven Lagae, Berten CeulemansTherapeutic Advances in Neurological Disorders|October 3, 2017
Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real worldTjalf Ziemssen, Katja ThomasTherapeutic Advances in Neurological Disorders|February 14, 2018
Advances in spinal muscular atrophy therapeuticsValeria Parente, Stefania CortiPageof 108